Cutera - CUTR Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CUTR shares.
View CUTR analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 1 year target prices for Cutera's shares. Their CUTR share price forecasts range from $33.00 to $68.00. On average, they expect the company's stock price to reach $51.50 in the next twelve months. This suggests a possible upside of 108.6% from the stock's current price.
View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts.

Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR shares have decreased by 44.2% and is now trading at $24.69.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our CUTR earnings forecast.

Cutera, Inc. (NASDAQ:CUTR) posted its earnings results on Tuesday, February, 28th. The medical device company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.09. The medical device company earned $67.40 million during the quarter, compared to analyst estimates of $69.52 million. Cutera had a negative net margin of 32.62% and a negative trailing twelve-month return on equity of 489.05%. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company posted ($0.22) earnings per share.

ETFs with the largest weight of Cutera (NASDAQ:CUTR) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), ALPS Disruptive Technologies ETF (DTEC), Invesco S&P SmallCap Health Care ETF (PSCH), Invesco DWA SmallCap Momentum ETF (DWAS), Principal Healthcare Innovators ETF (BTEC).

Cutera issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $277.00 million-$292.00 million, compared to the consensus revenue estimate of $300.65 million.

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (7.60%), Gamco Investors INC. ET AL (5.35%), Gamco Investors INC. ET AL (5.35%), Cowen AND Company LLC (3.42%), Eagle Asset Management Inc. (3.30%) and First Light Asset Management LLC (2.89%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends.

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CUTR stock can currently be purchased for approximately $24.69.

Cutera (NASDAQ:CUTR) has a market capitalization of $484.17 million and generates $252.40 million in revenue each year. The medical device company earns $-82,340,000.00 in net income (profit) each year or ($4.39) on an earnings per share basis.

The company employs 461 workers across the globe.

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.